CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Paion AG Company Snapshot
Paion AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Paion AG with three other pharmaceutical manufacturers in Europe: Norda ASA of Norway (2018 sales of 16.83 million Norwegian Kroner [US$1.83 million] ), Pharnext SA of France (2.69 million Euro [US$2.98 million] of which 100% was The conduct of research and development ), and BioPorto A/S which is based in Denmark (26.02 million Danish Kroner [US$3.86 million] of which 36% was Antibodies).

Sales Analysis. During the year ended December of 2018, sales at Paion AG were 2.77 million Euro (US$3.07 million). This is a sharp decrease of 52.4% versus 2017, when the company's sales were 5.81 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Paion AG
  Stock Performance Chart for Paion AG
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 2.00
(Figures in Euro)
1 Week 1.3%   13 Weeks -4.1%  
4 Weeks -16.9%   52 Weeks -18.1%  
 
Paion AG Key Data:
  Ticker: PA8 Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 2,765,900
(Year Ending Jan 2019).
Employees: 40
  Currency: Euro Market Cap: 127,489,825
  Fiscal Yr Ends: December Shares Outstanding: 63,904,674
  Share Type: Stammaktie Closely Held Shares: 5,804,705
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.